Stars and stripes in pancreatic cancer: Role of stellate cells and stroma in cancer progression

Frontiers in Physiology

Volumn 5 FEB, Issue , 2014, Pages

  Wilson, Jeremy S ^a,b   Pirola, Romano C ^a,b   Apte, Minoti V ^a,b  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b INGHAM INSTITUTE FOR APPLIED MEDICAL RESEARCH   (Australia)

Author keywords

Desmoplastic stromal reaction; Pancreatic cancer; Pancreatic stellate cells; Stromal therapeutic targets; Stromal tumor interactions

Indexed keywords

ELLAGIC ACID; EMBELIN; ENZYME INHIBITOR; FLUOROURACIL; FOLFIRINOX; FOLINIC ACID; GEMCITABINE; IRINOTECAN; OLMESARTAN; OXALIPLATIN; PACLITAXEL; PEGYLATED HUMAN RECOMBINANT PH20; PIRFENIDONE; UNCLASSIFIED DRUG;

CANCER CELL; CANCER GROWTH; CANCER STAGING; CELL FUNCTION; CELL INTERACTION; ENDOTHELIUM CELL; HUMAN; IMMUNOCOMPETENT CELL; IN VITRO STUDY; IN VIVO STUDY; NERVE CELL; NONHUMAN; PANCREAS CANCER; PANCREATIC STELLATE CELL; REVIEW; STROMA;

EID: 84895499536     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2014.00052     Document Type: Review

References (83)

1. Apte, M. V., Haber, P. S., Applegate, T. L., Norton, I. D., McCaughan, G. W., Korsten, M. A., et al. (1998). Periacinar stellate shaped cells in rat pancreas: identification, isolation, and culture. Gut 43, 128-133. doi: 10.1136/gut.43.1.128.
2. Apte, M. V., Park, S., Phillips, P. A., Santucci, N., Goldstein, D., Kumar, R. K., et al. (2004). Desmoplastic reaction in pancreatic cancer: role of pancreatic stellate cells. Pancreas 29, 179-187. doi: 10.1097/00006676-200410000-00002.
3. Apte, M. V., Pirola, R. C., and Wilson, J. S. (2012). Pancreatic stellate cells: a starring role in normal and diseased pancreas. Front. Physiol. 3:344. doi: 10.3389/fphys.2012.00344.
4. Apte, M. V., and Wilson, J. S. (2012). Dangerous liaisons: pancreatic stellate cells and pancreatic cancer cells. J. Gastroenterol. Hepatol. 27(Suppl. 2), 69-74. doi: 10.1111/j.1440-1746.2011.07000.x.
5. Apte, M. V., Wilson, J. S., Lugea, A., and Pandol, S. J. (2013). A starring role for stellate cells in the pancreatic cancer microenvironment. Gastroenterology 144, 1210-1219. doi: 10.1053/j.gastro.2012.11.037.
6. Arumugam, T., Brandt, W., Ramachandran, V., Moore, T. T., Wang, H., May, F. E., et al. (2011). Trefoil factor 1 stimulates both pancreatic cancer and stellate cells and increases metastasis. Pancreas 40, 815-822. doi: 10.1097/MPA.0b013e31821f6927.
7. Bachem, M. G., Schunemann, M., Ramadani, M., Siech, M., Beger, H., Buck, A., et al. (2005). Pancreatic carcinoma cells induce fibrosis by stimulating proliferation and matrix synthesis of stellate cells. Gastroenterology 128, 907-921. doi: 10.1053/j.gastro.2004.12.036.
8. Bailey, J. M., Swanson, B. J., Hamada, T., Eggers, J. P., Singh, P. K., Caffery, T., et al. (2008). Sonic hedgehog promotes desmoplasia in pancreatic cancer. Clin. Cancer Res. 14, 5995-6004. doi: 10.1158/1078-0432.CCR-08-0291.
9. Bayne, L. J., Beatty, G. L., Jhala, N., Clark, C. E., Rhim, A. D., Stanger, B. Z., et al. (2012). Tumor-derived granulocyte-macrophage colony-stimulating factor regulates myeloid inflammation and T cell immunity in pancreatic cancer. Cancer Cell 21, 822-835. doi: 10.1016/j.ccr.2012.04.025.
10. Beatty, G. L., Chiorean, E. G., Fishman, M. P., Saboury, B., Teitelbaum, U. R., Sun, W., et al. (2011). CD40 agonists alter tumor stroma and show efficacy against pancreatic carcinoma in mice and humans. Science 331, 1612-1616. doi: 10.1126/science.1198443.
11. Beatty, G. L., Torigian, D. A., Chiorean, E. G., Saboury, B., Brothers, A., Alavi, A., et al. (2013). A phase I study of an agonist CD40 monoclonal antibody (CP-870, 893) in combination with gemcitabine in patients with advanced pancreatic ductal adenocarcinoma. Clin. Cancer Res. 19, 6286-6295. doi: 10.1158/1078-0432.CCR-13-1320.
12. Ceyhan, G. O., Bergmann, F., Kadihasanoglu, M., Altintas, B., Demir, I. E., Hinz, U., et al. (2009). Pancreatic neuropathy and neuropathic pain-a comprehensive pathomorphological study of 546 cases. Gastroenterology 136, 177.e1-186.e1. doi: 10.1053/j.gastro.2008.09.029.
13. Ceyhan, G. O., Schafer, K. H., Kerscher, A. G., Rauch, U., Demir, I. E., Kadihasanoglu, M., et al. (2010). Nerve growth factor and artemin are paracrine mediators of pancreatic neuropathy in pancreatic adenocarcinoma. Ann. Surg. 251, 923-931. doi: 10.1097/SLA.0b013e3181d974d4.
14. Chang, D. Z., Ma, Y., Ji, B., Wang, H., Deng, D., Liu, Y., et al. (2013). Mast cells in tumor microenvironment promotes the in vivo growth of pancreatic ductal adenocarcinoma. Clin. Cancer Res. 17, 7015-7023. doi: 10.1158/1078-0432.CCR-11-0607.
15. Chari, S. T., Mohan, V., Pitchumoni, C. S., Viswanathan, M., Madanagopalan, N., and Lowenfels, A. B. (1994). Risk of pancreatic carcinoma in tropical calcifying pancreatitis: an epidemiologic study. Pancreas 9, 62-66. doi: 10.1097/00006676-199401000-00009.
16. Chauhan, V. P., Martin, J. D., Liu, H., Lacorre, D. A., Jain, S. R., Kozin, S. V., et al. (2013). Angiotensin inhibition enhances drug delivery and potentiates chemotherapy by decompressing tumour blood vessels. Nat. Commun. 4, 2516. doi: 10.1038/ncomms3516.
17. Chen, R., Pan, S., Ottenhof, N. A., de Wilde, R. F., Wolfgang, C. L., Lane, Z., et al. (2012). Stromal galectin-1 expression is associated with long-term survival in resectable pancreatic ductal adenocarcinoma. Cancer Biol. Ther. 13, 899-907. doi: 10.4161/cbt.20842.
18. Chu, G. C., Kimmelman, A. C., Hezel, A. F., and DePinho, R. A. (2007). Stromal biology of pancreatic cancer. J. Cell. Biochem. 101, 887-907. doi: 10.1002/jcb.21209.
19. Conroy, T., Desseigne, F., Ychou, M., Bouche, O., Guimbaud, R., Becouarn, Y., et al. (2011). FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. N. Engl. J. Med. 364, 1817-1825. doi: 10.1056/NEJMoa1011923.
20. Demir, I. E., Friess, H., and Ceyhan, G. O. (2012). Nerve-cancer interactions in the stromal biology of pancreatic cancer. Front. Physiol. 3:97. doi: 10.3389/fphys.2012.00097.
21. Duda, D. G., Duyverman, A. M., Kohno, M., Snuderl, M., Steller, E. J., Fukumura, D., et al. (2010). Malignant cells facilitate lung metastasis by bringing their own soil. Proc. Natl. Acad. Sci. U.S.A. 107, 21677-21682. doi: 10.1073/pnas.1016234107.
22. Edderkaoui, M., Lugea, A., Hui, H., Eibl, G., Lu, Q. Y., Moro, A., et al. (2013). Ellagic acid and embelin affect key cellular components of pancreatic adenocarcinoma, cancer, and stellate cells. Nutr. Cancer 65, 1232-1244. doi: 10.1080/01635581.2013.832779.
23. Ene-Obong, A., Clear, A. J., Watt, J., Wang, J., Fatah, R., Riches, J. C., et al. (2013). Activated pancreatic stellate cells sequester CD8+ T-cells to reduce their infiltration of the juxtatumoral compartment of pancreatic ductal adenocarcinoma. Gastroenterology. 145, 1121-1132. doi: 10.1053/j.gastro.2013.07.025.
24. Erkan, M., Kleeff, J., Gorbachevski, A., Reiser, C., Mitkus, T., Esposito, I., et al. (2007). Periostin creates a tumor-supportive microenvironment in the pancreas by sustaining fibrogenic stellate cell activity. Gastroenterology 132, 1447-1464. doi: 10.1053/j.gastro.2007.01.031.
25. Erkan, M., Reiser-Erkan, C., Michalski, C. W., Deucker, S., Sauliunaite, D., Streit, S., et al. (2009). Cancer-stellate cell interactions perpetuate the hypoxia-fibrosis cycle in pancreatic ductal adenocarcinoma. Neoplasia 11, 497-508. doi: 10.1593/neo.81618.
26. Feldmann, G., Dhara, S., Fendrich, V., Bedja, D., Beaty, R., Mullendore, M., et al. (2007). Blockade of hedgehog signaling inhibits pancreatic cancer invasion and metastases: a new paradigm for combination therapy in solid cancers. Cancer Res. 67, 2187-2196. doi: 10.1158/0008-5472.CAN-06-3281.
27. Fujiwara, K., Ohuchida, K., Ohtsuka, T., Mizumoto, K., Shindo, K., Ikenaga, N., et al. (2013). Migratory activity of CD105+ pancreatic cancer cells is strongly enhanced by pancreatic stellate cells. Pancreas 2042, 1283-1290. doi: 10.1097/MPA.0b013e318293e7bd.
28. Fukushima, N., Kikuchi, Y., Nishiyama, T., Kudo, A., and Fukayama, M. (2008). Periostin deposition in the stroma of invasive and intraductal neoplasms of the pancreas. Mod. Pathol. 21, 1044-1053. doi: 10.1038/modpathol.2008.77.
29. Funahashi, H., Satake, M., Dawson, D., Huynh, N. A., Reber, H. A., Hines, O. J., et al. (2007). Delayed progression of pancreatic intraepithelial neoplasia in a conditional Kras(G12D) mouse model by a selective cyclooxygenase-2 inhibitor. Cancer Res. 67, 7068-7071. doi: 10.1158/0008-5472.CAN-07-0970.
30. Gabitass, R. F., Annels, N. E., Stocken, D. D., Pandha, H. A., and Middleton, G. W. (2011). Elevated myeloid-derived suppressor cells in pancreatic, esophageal and gastric cancer are an independent prognostic factor and are associated with significant elevation of the Th2 cytokine interleukin-13. Cancer Immunol. Immunother. 60, 1419-1430. doi: 10.1007/s00262-011-1028-0.
31. Guerra, C., and Barbacid, M. (2013). Genetically engineered mouse models of pancreatic adenocarcinoma. Mol. Oncol. 7, 232-247. doi: 10.1016/j.molonc.2013.02.002.
32. Haas, S. L., Fitzner, B., Jaster, R., Wiercinska, E., Gaitantzi, H., Jesnowski, R., et al. (2009). Transforming growth factor-beta induces nerve growth factor expression in pancreatic stellate cells by activation of the ALK-5 pathway. Growth Factors 27, 289-299. doi: 10.1080/08977190903132273.
33. Hamada, S., Masamune, A., and Shimosegawa, T. (2013). Inflammation and pancreatic cancer: disease promoter and new therapeutic target. J. Gastroenterol. doi: 10.1007/s00535-013-0915-x. [Epub ahead of print].
34. Hamada, S., Masamune, A., Takikawa, T., Suzuki, N., Kikuta, K., Hirota, M., et al. (2012). Pancreatic stellate cells enhance stem cell-like phenotypes in pancreatic cancer cells. Biochem. Biophys. Res. Commun. 421, 349-354. doi: 10.1016/j.bbrc.2012.04.014.
35. Hanahan, D., and Weinberg, R. A. (2011). Hallmarks of cancer: the next generation. Cell 144, 646-674. doi: 10.1016/j.cell.2011.02.013.
36. Hwang, R. F., Moore, T., Arumugam, T., Ramachandran, V., Amos, K. D., Rivera, A., et al. (2008). Cancer-associated stromal fibroblasts promote pancreatic tumor progression. Cancer Res. 68, 918-926. doi: 10.1158/0008-5472.CAN-07-5714.
37. Hwang, R. F., Moore, T. T., Hattersley, M. M., Scarpitti, M., Yang, B., Devereaux, E., et al. (2012). Inhibition of the hedgehog pathway targets the tumor-associated stroma in pancreatic cancer. Mol. Cancer Res. 10, 1147-1157. doi: 10.1158/1541-7786.MCR-12-0022.
38. Ijichi, H., Chytil, A., Gorska, A. E., Aakre, M. E., Bierie, B., Tada, M., et al. (2011). Inhibiting Cxcr2 disrupts tumor-stromal interactions and improves survival in a mouse model of pancreatic ductal adenocarcinoma. J. Clin. Invest. 121, 4106-4117. doi: 10.1172/JCI42754.
39. Ikenaga, N., Ohuchida, K., Mizumoto, K., Cui, L., Kayashima, T., Morimatsu, K., et al. (2010). CD10+ pancreatic stellate cells enhance the progression of pancreatic cancer. Gastroenterology 139, 1041-1051, 1051.e1-1051.e8. doi: 10.1053/j.gastro.2010.05.084.
40. Ino, Y., Yamazaki-Itoh, R., Shimada, K., Iwasaki, M., Kosuge, T., Kanai, Y., et al. (2013). Immune cell infiltration as an indicator of the immune microenvironment of pancreatic cancer. Br. J. Cancer 108, 914-923. doi: 10.1038/bjc.2013.32.
41. Ito, T. (1951). Cytological studies on stellate cells of Kupffer and fat storing cells in the capillary wall of the human liver (Japanese abstract). Acta Anat. Nippon 26:42.
42. Jacobetz, M. A., Chan, D. S., Neesse, A., Bapiro, T. E., Cook, N., Frese, K. K., et al. (2013). Hyaluronan impairs vascular function and drug delivery in a mouse model of pancreatic cancer. Gut 62, 112-120. doi: 10.1136/gutjnl-2012-302529.
43. Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., and Forman, D. (2011). Global cancer statistics. CA Cancer J. Clin. 61, 69-90. doi: 10.3322/caac.20107.
44. Ji, B., Bi, Y., Simeone, D., Mortensen, R. M., and Logsdon, C. D. (2001). Human pancreatic acinar cells lack functional responses to cholecystokinin and gastrin. Gastroenterology 121, 1380-1390. doi: 10.1053/gast.2001.29557.
45. Ji, B., Bi, Y., Simeone, D., Mortensen, R. M., and Logsdon, C. D. (2002). Human pancreatic acinar cells do not respond to cholecystokinin. Pharmacol. Toxicol. 91, 327-332. doi: 10.1034/j.1600-0773.2002.910610.x.
46. Kordes, C., Sawitza, I., Gotze, S., and Haussinger, D. (2013). Stellate cells from rat pancreas are stem cells and can contribute to liver regeneration. PLoS ONE 7:e51878. doi: 10.1371/journal.pone.0051878.
47. Kozono, S., Ohuchida, K., Eguchi, D., Ikenaga, N., Fujiwara, K., Cui, L., et al. (2013). Pirfenidone inhibits pancreatic cancer desmoplasia by regulating stellate cells. Cancer Res. 73, 2345-2356. doi: 10.1158/0008-5472.CAN-12-3180.
48. Kraman, M., Bambrough, P. J., Arnold, J. N., Roberts, E. W., Magiera, L., Jones, J. O., et al. (2010). Suppression of antitumor immunity by stromal cells expressing fibroblast activation protein-alpha. Science 330, 827-830. doi: 10.1126/science.1195300.
49. Lee, U. E., and Friedman, S. L. (2011). Mechanisms of hepatic fibrogenesis. Best Pract. Res. Clin. Gastroenterol. 25, 195-206. doi: 10.1016/j.bpg.2011.02.005.
50. Lu, J., Zhou, S., Siech, M., Habisch, H., Seufferlein, T., and Bachem, M. G. (2014). Pancreatic stellate cells promote hapto-migration of cancer cells through collagen I-mediated signalling pathway. Br. J. Cancer. 110, 409-420. doi: 10.1038/bjc.2013.706.
51. Ma, Y., Hwang, R. F., Logsdon, C. D., and Ullrich, S. E. (2013). Dynamic mast cell-stromal cell interactions promote growth of pancreatic cancer. Cancer Res. 73, 3927-3937. doi: 10.1158/0008-5472.CAN-12-4479.
52. Mace, T. A., Bloomston, M., and Lesinski, G. B. (2013). Pancreatic cancer-associated stellate cells: a viable target for reducing immunosuppression in the tumor microenvironment. Oncoimmunology 2:e24891. doi: 10.4161/onci.24891.
53. Mantoni, T. S., Lunardi, S., Al-Assar, O., Masamune, A., and Brunner, T. B. (2011). Pancreatic stellate cells radioprotect pancreatic cancer cells through beta1-integrin signaling. Cancer Res. 71, 3453-3458. doi: 10.1158/0008-5472.CAN-10-1633.
54. Masamune, A., Hamada, S., Kikuta, K., Takikawa, T., Miura, S., Nakano, E., et al. (2013). The angiotensin II type I receptor blocker olmesartan inhibits the growth of pancreatic cancer by targeting stellate cell activities in mice. Scand. J. Gastroenterol. 48, 602-609. doi: 10.3109/00365521.2013.777776.
55. Masamune, A., Kikuta, K., Watanabe, T., Satoh, K., Hirota, M., and Shimosegawa, T. (2008b). Hypoxia stimulates pancreatic stellate cells to induce fibrosis and angiogenesis in pancreatic cancer. Am. J. Physiol. Gastrointest. Liver Physiol. 295, G709-G717. doi: 10.1152/ajpgi.90356.2008.
56. Masamune, A., Kikuta, K., Watanabe, T., Satoh, K., Satoh, A., and Shimosegawa, T. (2008a). Pancreatic stellate cells express Toll-like receptors. J. Gastroenterol. 43, 352-362. doi: 10.1007/s00535-008-2162-0.
57. Masamune, A., Watanabe, T., Kikuta, K., and Shimosegawa, T. (2009). Roles of pancreatic stellate cells in pancreatic inflammation and fibrosis. Clin. Gastroenterol. Hepatol. 7, S48-S54. doi: 10.1016/j.cgh.2009.07.038.
58. Mato, E., Lucas, M., Petriz, J., Gomis, R., and Novials, A. (2009). Identification of a pancreatic stellate cell population with properties of progenitor cells: new role for stellate cells in the pancreas. Biochem. J. 421, 181-191. doi: 10.1042/BJ20081466.
59. Mews, P., Phillips, P., Fahmy, R., Korsten, M., Pirola, R., Wilson, J., et al. (2002). Pancreatic stellate cells respond to inflammatory cytokines: potential role in chronic pancreatitis. Gut 50, 535-541. doi: 10.1136/gut.50.4.535.
60. Murphy, J. A., Criddle, D. N., Sherwood, M., Chvanov, M., Mukherjee, R., McLaughlin, E., et al. (2008). Direct activation of cytosolic Ca2+ signaling and enzyme secretion by cholecystokinin in human pancreatic acinar cells. Gastroenterology 135, 632-641. doi: 10.1053/j.gastro.2008.05.026.
61. Neuzillet, C., Tijeras-Raballand, A., Cros, J., Faivre, S., Hammel, P., and Raymond, E. (2013). Stromal expression of SPARC in pancreatic adenocarcinoma. Cancer Metastasis Rev. 32, 585-602. doi: 10.1007/s10555-013-9439-3.
62. Olive, K. P., Jacobetz, M. A., Davidson, C. J., Gopinathan, A., McIntyre, D., Honess, D., et al. (2009). Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer. Science 324, 1457-1461. doi: 10.1126/science.1171362.
63. Pandol, S., Gukovskaya, A., Edderkoui, M., Dawson, D., Eibl, G., and Lugea, A. (2012). Epidemiology, risk factors, and the promotion of pancreatic cancer: role of the stellate cell. J. Gastroenterol. Hepatol. 27(Suppl. 2), 127-134. doi: 10.1111/j.1440-1746.2011.07013.x.
64. Phillips, P. A., Yang, L., Shulkes, A., Vonlaufen, A., Poljak, A., Bustamante, S., et al. (2010). Pancreatic stellate cells produce acetylcholine and may play a role in pancreatic exocrine secretion. Proc. Natl. Acad. Sci. U.S.A. 107, 17397-17402. doi: 10.1073/pnas.1000359107.
65. Provenzano, P. P., Cuevas, C., Chang, A. E., Goel, V. K., Von Hoff, D. D., and Hingorani, S. R. (2012). Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma. Cancer Cell 21, 418-429. doi: 10.1016/j.ccr.2012.01.007.
66. Shimizu, K., Hashimoto, K., Tahara, J., Imaeda, H., Andoh, A., and Shiratori, K. (2012). Pancreatic stellate cells do not exhibit features of antigen-presenting cells. Pancreas 41, 422-427. doi: 10.1097/MPA.0b013e31822e673b.
67. Siegel, R., Naishadham, D., and Jemal, A. (2013). Cancer statistics, (2013). CA Cancer J. Clin. 63, 11-30. doi: 10.3322/caac.21166.
68. Tahara, J., Shimizu, K., and Shiratori, K. (2008). Engulfment of necrotic acinar cells by pancreatic stellate cells inhibits pancreatic fibrogenesis. Pancreas 37, 69-74. doi: 10.1097/MPA.0b013e318160a5cb.
69. Tang, D., Yuan, Z., Xue, X., Lu, Z., Zhang, Y., Wang, H., et al. (2012). High expression of Galectin-1 in pancreatic stellate cells plays a role in the development and maintenance of an immunosuppressive microenvironment in pancreatic cancer. Int. J. Cancer 130, 2337-2348. doi: 10.1002/ijc.26290.
70. Thayer, S. P., di Magliano, M. P., Heiser, P. W., Nielsen, C. M., Roberts, D. J., Lauwers, G. Y., et al. (2003). Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis. Nature 425, 851-856. doi: 10.1038/nature02009.
71. Thomasova, D., Mulay, S. R., Bruns, H., and Anders, H. J. (2012). p53-independent roles of MDM2 in NF-kappaB signaling: implications for cancer therapy, wound healing, and autoimmune diseases. Neoplasia 14, 1097-1101. doi: 10.1593/neo.121534.
72. Von Hoff, D. D., Ervin, T., Arena, F. P., Chiorean, E. G., Infante, J., Moore, M., et al. (2013). Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine. N. Engl. J. Med. 369, 1691-1703. doi: 10.1056/NEJMoa1304369.
73. Von Hoff, D. D., Ramanathan, R. K., Borad, M. J., Laheru, D. A., Smith, L. S., Wood, T. E., et al. (2011). Gemcitabine plus nab-paclitaxel is an active regimen in patients with advanced pancreatic cancer: a phase I/II trial. J. Clin. Oncol. 29, 4548-4554. doi: 10.1200/JCO.2011.36.5742.
74. Vonlaufen, A., Joshi, S., Qu, C., Phillips, P. A., Xu, Z., Parker, N. R., et al. (2008a). Pancreatic stellate cells: partners in crime with pancreatic cancer cells. Cancer Res. 68, 2085-2093. doi: 10.1158/0008-5472.CAN-07-2477.
75. Vonlaufen, A., Phillips, P. A., Xu, Z., Goldstein, D., Pirola, R. C., Wilson, J. S., et al. (2008b). Pancreatic stellate cells and pancreatic cancer cells: an unholy alliance. Cancer Res. 68, 7707-7710. doi: 10.1158/0008-5472.CAN-08-1132.
76. Vonlaufen, A., Phillips, P. A., Xu, Z., Zhang, X., Yang, L., Pirola, R. C., et al. (2011). Withdrawal of alcohol promotes regression while continued alcohol intake promotes persistence of LPS-induced pancreatic injury in alcohol-fed rats. Gut 60, 238-246. doi: 10.1136/gut.2010.211250.
77. Wake, K., Motomatsu, K., and Senoo, H. (1987). Stellate cells storing retinol in the liver of adult lamprey, Lampetra japonica. Cell Tissue Res. 249, 289-299. doi: 10.1007/BF00215511.
78. Watari, N., Hotta, Y., and Mabuchi, Y. (1982). Morphological studies on a vitamin A-storing cell and its complex with macrophage observed in mouse pancreatic tissues following excess vitamin A administration. Okajimas Folia Anat. Jpn. 58, 837-858.
79. Whitcomb, D., and Greer, J. (2009). Germ-line mutations, pancreatic inflammation, and pancreatic cancer. Clin. Gastroenterol. Hepatol. 7, S29-S34. doi: 10.1016/j.cgh.2009.07.032.
80. Whitcomb, D. C. (2004). Inflammation and Cancer V. Chronic pancreatitis and pancreatic cancer. Am. J. Physiol. Gastrointest. Liver Physiol. 287, G315-G319. doi: 10.1152/ajpgi.00115.2004.
81. Xu, Z., Vonlaufen, A., Phillips, P. A., Fiala-Beer, E., Zhang, X., Yang, L., et al. (2010). Role of pancreatic stellate cells in pancreatic cancer metastasis. Am. J. Pathol. 177, 2585-2596. doi: 10.2353/ajpath.2010.090899.
82. Yardley, D. A. (2013). nab-Paclitaxel mechanisms of action and delivery. J. Control. Release 170, 365-372. doi: 10.1016/j.jconrel.2013.05.041.
83. Yoshida, S., Ujiki, M., Ding, X. Z., Pelham, C., Talamonti, M. S., Bell, R. H., et al. (2005). Pancreatic stellate cells (PSCs) express cyclooxygenase-2 (COX-2) and pancreatic cancer stimulates COX-2 in PSCs. Mol. Cancer 4, 27. doi: 10.1186/1476-4598-4-27.